Szerző: " Gisbert Javier P."

Garcia Maria Jose; Riestra Sabino; Amiot Aurelien; Julsgaard Mette; Garcia de la Filia Irene; Calafat Margalida; Aguas Mariam; de la Pena Luisa; Roig Cristina; Caballol Berta; Casanova Maria Jose; Farkas Klaudia; Boysen Trine; Bujanda Luis; Cuaran Camila; Dobru Daniela; Fousekis Fotios; Gargallo-Puyuelo Carla Jerusalen; Savarino Edoardo; Calvet Xavier; Huguet Jose Maria; Kupcinskas Limas; Lopez-Cardona Julia; Raine Tim; van Oostrom Joep; Gisbert Javier P.; Chaparro Maria: Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 59 (10). pp. 1249-1259. ISSN 0269-2813 (2024)

Peyrin-Biroulet Laurent; Rahier Jean-François; Kirchgesner Julien; Abitbol Vered; Sebastian Shaji; Armuzzi Alessandro; Karmiris Konstantinos; Gisbert Javier P.; Bossuyt Peter; Helwig Ulf; Burisch Johan; Yanai Henit; Glen A. Doherty; Molnár Tamás; Kollaborációs Szervezet: I-CARE Collaborator Group: I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 21 (3). pp. 771-788. ISSN 1542-3565 (2023)

Festa Stefano; Zerboni Giulia; Derikx Lauranne A. A. P.; Ribaldone Davide Giuseppe; Dragoni Gabriele; Buskens Christianne; Dijkum, van Els Nieveen; Pugliese Daniela; Panzuto Francesco; Krela-Kaźmierczak Iwona; Mintz Hilla Reiss; Shitrit Ariella Bar-Gil; Chaparro Marìa; Gisbert Javier P.; Molnár Tamás: Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease : An ECCO CONFER Multicentre Case Series.
JOURNAL OF CROHNS & COLITIS, 16 (6). pp. 940-945. ISSN 1873-9946 (2022)

Pauwels Renske W. M.; van der Woude C. Janneke; Nieboer Daan; Steyerberg Ewout W.; Casanova Maria J.; Gisbert Javier P.; Kennedy Nick A.; Lees Charlie W.; Louis Edouard; Molnár Tamás; Szántó Kata Judit; Leo Eduardo; Bots Steven; Downey Robert; Farkas Klaudia; Kollaborációs szervezet: CEASE Study Group: Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 20 (8). pp. 1671-1686. ISSN 1542-3565 (2022)